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INTRODUCTION
De novo synthesis of biotin (aka vitamin H or B7) is an important metabolic activity for microorganisms, fungi and plants, which is not present in humans [1] . In bacteria, biotin serves as an essential cofactor for biotin-dependent enzymes, namely pyruvate carboxylase (PC) to replenish the Krebs cycle and acyl-CoA carboxylase (ACC) for membrane biogenesis and maintenance [2] , [3] , [4] and [5] . As the cell membrane provides a defensive barrier against environmental toxins, host immune factors and antibiotic agents [6] and [7] , the metabolic pathways related to the synthesis of membrane lipids have been suggested as promising targets for the development of new antibiotics. Genetic studies have revealed important roles for biotin biosynthesis in Mycobacterium tuberculosis during growth, infection and the latency phase, thus establishing this pathway as a potential drug target for new anti-tuberculosis therapies [3] , [8] , [9] , [10] , [11] and [12] . In addition, biotin biosynthesis has been intensively studied in other bacteria and the enzymes involved in the pathway have been implicated in bacterial virulence during infection and intracellular replication [13] .
Dethiobiotin synthetase (DTBS, EC 6.3.3.3, encoded by bioD) controls the penultimate step of the biotin biosynthesis pathway, catalysing the closure of the ureido ring of dethiobiotin (DTB) from (7R, 8S)-7,8-diaminopelargonic acid (DAPA) using CO 2 and a nucleotide triphosphate (NTP). The reaction mechanism has been proposed to involve three discrete steps, which are (1) the formation of N7-carbamate, (2) the formation of the carbamic-phosphoric acid anhydride, and (3) the closure of the ureido ring with the release of inorganic phosphate [14] . The amino acid residues required for binding the DAPA substrate and subsequent catalysis have been well characterized, with X-ray crystal structures available for the enzymes from Escherichia coli, M. tuberculosis, Helicobacter pylori, and Francisella tularensis [15] , [16] , [17] and [18] . However, the molecular details of NTP binding are less well defined, especially for M. tuberculosis DTBS (MtDTBS) where there is currently no crystal structure of the enzyme in complex with NTP. From the available structural data, the NTP binding site is divided into two discrete subsites; the phosphate-binding region (also known as the P-loop or Walker A motif) and the nucleoside-binding pocket. In E. coli DTBS (EcDTBS), a conformational change involving the P-loop (Gly8-X-X-X-X-X-Gly14-Lys15-Th16) was observed following phosphate binding [16] . In contrast, a comparison of available MtDTBS structures revealed no homologous conformational change upon the binding of inorganic phosphate [15] . Comparison of the bacterial DTBS homologues revealed considerable structural differences in nucleoside recognition at the C-terminal region of DTBS [18] . Previous attempts to characterize DTBS have been restricted by the lack of facile assays. DTBS activity was commonly measured with a spectrophotometric assay by monitoring ADP production through the coupling of pyruvate kinase and lactate dehydrogenase [19] , [16] , [19] and [16] . Using two additional enzymes in the reaction is less than desirable for high-throughput screening applications. An alternative radioactive-labeled carbon fixation assay has been reported for detecting the formation of the acid-stable [ 14 C]DTB product using [ 14 C]CO 2 [19] . However, complicated procedures are required to remove excess [ 14 C]CO 2 from the reaction. Recently, a continuous fluorescent assay was developed to detect the coupled action of DAPAS and DTBS, based on the displacement of a dethiobiotin fluorescent probe bound to streptavidin by the DTB product [20] . Although, it is possible to adapt this continuous fluorescent assay for detecting the DTBS activity alone, the fluorescent probe is not commercially available and must be synthesized via at least four steps [21] and [20] .
In this study, we successfully developed two facile, homogeneous assays to study DTBS. These enabling technologies will be beneficial for future drug discovery efforts.
Here the assays were employed to characterize DTBS from E. coli and M. tuberculosis.
The specificity of NTP binding and utilization was investigated. Stark differences were observed between the two enzymes with EcDTBS having highest preference for ATP whereas MtDTBS showed equal potency for a broad panel of NTPs. A competitive ATP binding assay together with surface plasmon resonance analysis (SPR) showed that CTP bound to the mycobacterium homologue with greatest affinity. For the first time, the structure of MtDTBS was resolved in complex with a nucleotide, namely CTP. X-ray crystallography in combination with mutagenesis studies revealed a role for N175 in
EcDTBS in discriminatory binding of NTPs.
MATERIALS AND METHODS

Cloning and plasmid construction.
The bioD genes encoding DTBS from M. tuberculosis strain H37Rv (Gene ID: 886338) and E. coli strain K-12 (Gene ID: 945387), both containing an N-terminal hexa-histidine tag, were synthesized as codon optimized genes for expression in E. coli and ligated into the pMA vector (GENEART ® Gene Synthesis, Life Technologies Australia Pty Ltd.).
Site directed mutagenesis was performed using the QuickChange® site-directed PCR mutagenesis kit (Stratagene) with oligonucleotides synthesized at GeneWorks Pty Ltd (Adelaide, Australia). All oligonucleotides used in this study are listed in Table S1 . The
MtDTBS-G169N mutation was constructed using oligonucleotides A1 and A2 whereas the two mutants of EcDTBS were constructed with oligonucleotides A3 and A4 for
EcDTBS-N175G and A5 and A6 for EcDTBS-N175A. For recombinant expression in E.
coli, the coding regions were subcloned into NcoI and HindIII treated pET16b vector (Novagen). All constructs were verified by DNA sequencing using the Gene Sequencing Service, SA Pathology (Adelaide, Australia).
Expression and Protein Purification
DTBS proteins were recombinantly expressed in E. coli strain BL21(DE3) (Invitrogen).
Cultured cells were used to inoculate LB medium containing 0.1 mg ml -1 ampicillin and grown at 37 ˚C until early log phase when protein expression was induced with 0. The identities of the purified wildtype proteins were confirmed by enzyme assay and liquid chromatography-electrospray ionization tandem mass spectrometry, whilst the molecular weight of the mutants were confirmed using MALDI mass spectrometry, as described in Supporting Methods. All mass spectrometry services were performed at the Adelaide Proteomics Center, The University of Adelaide.
Preparation of Nucleotide triphosphates
Solutions of NTPs were prepared by dissolving solid compound in sterile water and adjusting the pH to 7.0 with sodium hydroxide. The final concentration was determined by measuring absorbance at 260 nm, as described in [22] . For assays, the NTPs were first mixed with an equimolar concentration of MgCl 2 solution to form a MgNTP complex.
DTBS Enzyme Assay
The activity of DTBS was determined using fluorescence-polarization ( PerkinElmer 2030 Plate Reader using polarization mode set to 485 nm excitation and 535 nm emission [23] . FP is defined as the difference of the emission light intensity parallel and perpendicular to the excitation light plane; normalized by the total fluorescence emission intensity [24] and [25] . The concentration of enzymatically generated DTB was calculated from a standard curve generated with each experiment (see example in The data were fit to the Michaelis-Menten equation and the V max and K m were then calculated using GraphPad Prism 6 (GraphPad Software, Inc.).
DTBS ATP-binding Assay
The 
Surface Plasmon Resonance (SPR)
The kinetics of the interaction between DTBS and NTP were analyzed using a BIAcore T100. Details of the protein immobilization and data analysis are described in the Supporting Information. Flow cell 1 of the sensor chip was used as reference to correct for bulk refractive index changes. Immobilized bovine serum albumin was also employed as control for non-specific binding. Varying concentrations of MgNTP were prepared in running buffer (10 mM HEPES (pH 7.4), 150 mM NaCl and 0.005% (v/v) surfactant P20) then injected across the sensor surface. The equilibrium binding constant (K D ) was determined using an affinity-steady state 1:1 model in BIAcore T100 evaluation software (GE Healthcare).
X-ray Crystallography
MtDTBS was concentrated to 10 mg ml -1 , to which a final concentration of 1 mM CTP was added and incubated for 1 hour at room temperature. The complex was crystallized using the hanging drop vapour diffusion method at room temperature. Crystals grew from the following range of buffers: 0.8 -1.2 M ammonium sulphate, 0.1 M Tris pH 7 -8.5 with 10 % glycerol. X-ray diffraction data was collected in-house using a Rigaku RUH2R rotating copper anode X-ray source equipped with Osmic confocal optics and an R-Axis IV detector. Crystals were flash frozen and the diffraction data collected with cryo-cooling using an Oxford Cryosystems 700 Series cryostream at 100 K. The diffraction data was indexed, merged and integrated using XDS [26] , which was also used to produce the final MTZ files required for structure refinement. Initial phases of the structure were determined with PHASER [27] using the co-ordinates of MtDTBS (PDB ID: 3FGN) as a search model. The model of MtDTBS in complex with CTP was built with cycles of manual modeling with COOT [28] and refinement with PHENIX [29] .
The co-ordinates were deposited in the protein database 4WOP.
RESULTS
Purification and biochemical characterization of M. tuberculosis and E. coli DTBS.
Genes encoding the two bacterial DTBS enzymes were synthesized and cloned into the pET-16b plasmid for recombinant expression in E. coli. A hexa-histidine tag was engineered onto the N-terminus of the proteins to facilitate purification using immobilized nickel affinity chromatography. EcDTBS expressed as a soluble protein at 37˚C, whereas the optimal conditions for the M. tuberculosis equivalent were overnight at 25˚C. SDS-PAGE analysis of the IMAC purified material revealed high purity (>95%) and a single product corresponding to the expected molecular mass of 23.5 kDa for
MtDTBS or 25.1 kDa for EcDTBS (Fig. S1 ). Liquid chromatography-electrospray ionization tandem mass spectrometry analysis of the tryptic peptides confirmed the identity of the purified material, with 47% coverage for MtDTBS and 41% coverage for EcDTBS (Table S2) . SEC-MALS analysis revealed that >98% of the total proteins eluted at a molecular mass consistent with a homodimer (Fig. S2A&B) . Interestingly, MS/MS sequencing failed to detect endogenous E. coli protein in the MtDTBS preparation implying the recombinant mycobacterial protein did not form heterodimers with the host protein.
Enzyme Activity and Assay Development
To characterize the purified enzymes two alternative assays were developed to measure enzyme activity and ATP binding. Both assays incorporated fluorescence polarization technology to quantify the difference in anisotropy of a fluorescent tracer between its free and protein-bound states [30] , [31] and [32] . The enzyme assay exploits the observation that DTB, enzymatically produced by DTBS, effectively competes with commercially available fluorescein-biotin (M r 831 Da) to bind streptavidin (M r 67 000 Da). Notably, the tracer did not bind to DTBS (Fig. S3A ). Furthermore DTB, but not the substrate DAPA, could displace the tracer from streptavidin (Fig. S3B) [15, 33] .
The activity of the DTBS enzymes was initially measured in the presence of each of a panel of NTPs at 0.3 mM. Unexpectedly, MtDTBS was able to utilize any of ATP, CTP, GTP, ITP, TTP and UTP (Fig. 1 ). These observations were in stark contrast to the E.
coli homologue where the enzyme had greatest preference for ATP, a result consistent with published literature [33] . Further kinetic analysis showed that MtDTBS utilized all nucleotides with similar K M 's and k cat 's while EcDTBS could use CTP and GTP albeit with more than 100-fold and 150-fold higher K M s than ATP, respectively ( Fig. 2 & Table   1 ). This nucleotide specificity was confirmed in the ATP-binding assay where all nucleotides could compete effectively against the ATP-BODiPY tracer for binding MtDTBS (Fig. 3) . Here, CTP was observed to have the greatest binding affinity with a 6-fold lower IC 50 than ATP in MtDTBS (Table 2) . Consistent with the enzyme assay, ATP was the preferred NTP in EcDTBS with >10-fold lower IC 50 values than CTP and GTP. SPR analysis was also employed to measure the bimolecular interactions between DTBS and nucleotide triphosphates. Again, this confirmed that both ATP and CTP bound to MtDTBS (Fig. 4A) with CTP demonstrating the highest affinity (K D CTP = 17.2 ± 1.7 µM; ATP = 335.1 ± 96.0 µM) (Fig. S4A&B) . In contrast, EcDTBS was highly selective for ATP (K D of 347.9 ± 75.1 µM) over CTP where no response was observed ( Fig. 4B and Fig. S4C ). Injection of NTPs over either an empty flow cell or immobilized bovine serum albumin (BSA), performed concurrently with the immobilized DTBS experiment, resulted in negligible response (Fig 4D, and data not shown) . This confirmed the specificity of NTP binding to the DTBS enzymes.
3.3 X-ray Crystallography -To date there have been no X-ray structures available of
MtDTBS in complex with a nucleotide triphosphate. To better understand the molecular basis of ligand binding, MtDTBS was crystallized in complex with CTP (Fig. 5) . The structure was determined to 2.3 Å; data collection, refinement, and geometric statistics are provided in Table S3 . Repeated attempts to crystallize the enzyme with ATP were unsuccessful. As expected, our structures were consistent with the α/β-fold observed in the published structures for E. coli, H. pylori and F. tularensis DTBS [18] . and the beta carbon of Ala 201 stabilize the sugar in its binding pocket (Fig. S5 ). CTP adopted a bent conformation with rotation around the C-N bond between ribosyl and cytosinyl groups to allow the pyrimidine ring to bind in its appropriate pocket. Two hydrophobic interactions are observed between the pyrimidine ring and the protein, namely C5 with Ser170 and C6 with Val17 in the P-loop. The interaction is further stabilized through three hydrogen-bonding interactions with the pyrimidine ring. What is noteworthy is that all three of these bonds are with the protein backbone and not with amino acid side chains; O2 bonds with the nitrogen of Ala201 whilst N4 bonds with the backbone oxygen atoms of Gly169 and Pro197.
The lack of side chain interactions contacting the nucleotide base observed in MtDTBS is in contrast to the E. coli homologue, in which the carboxamide side chain on Asn175 forms hydrogen-bonding interactions with N6 and N7 on the purine ring of ATP (Fig. 6) [14]. This side chain interaction is also present in H. pylori, which selectively binds ATP [18] . It has previously been proposed that side chain interactions involving asparagine play a key role in nucleotide specificity [34] and [18] , but this has not been tested experimentally. To uncover the function of this asparagine in NTP binding, an asparagine residue was engineered into the M. tuberculosis enzyme at the structurally equivalent position to Asn175 in EcDTBS, thereby generating MtDTBS-G169N.
Likewise, two muteins of the E. coli homologue were generated by substituting Asn175 with either glycine or alanine (producing EcDTBS-N175G and EcDTBS-N175A).
Purification and biochemical characterization of mutants
EcDTBS-N175G and EcDTBS-N175A were expressed as soluble proteins in E. coli allowing their purification by IMAC. In contrast, MtDTBS-G169N formed inclusion bodies and, therefore, required refolding. MtDTBS-G169N was purified using IMAC under denaturing conditions and then refolded by a four step-wise dialysis procedure to restore enzyme activity. SEC-MALS analysis revealed that only 25% of the refolded MtDTBS-G169N material eluted as a homodimer, with the majority of the material forming inactive protein aggregates (Fig. S2C) 
DISCUSSION
It has previously been proposed that DTBS is more similar to GTP-binding proteins than ATP-dependent enzymes based on its fold [35] [18] . The first asparagine in this motif (numbering N175 in EcDTBS) was suggested to be an evolutionary relic from a protein able to bind both adenosine and guanine nucleotides and provides nucleotide specificity [34] and [18] . Curiously, in the current study, DTBS from M. tuberculosis was shown to be capable of binding ATP and GTP, as well as other nucleotides, with similar affinities despite the enzyme being devoid of the equivalent asparagine. Here, for the first time,
we present the structure of MtDTBS in complex with a nucleotide (CTP). The structural data revealed that the hydrogen bonding interactions with the nucleoside occurred exclusively through the peptide backbone of the enzyme, and not via side chains.
Indeed, with the absence of Asn175 (equivalent position of G169 in MtDTBS) or the reduction of hydrophobic interactions at C5 of the pyrimidine ring with S170 (MtDTBS-S170D, data not shown), the MtDTBS retained the ability to bind all nucleotides.
To further understand the molecular basis of NTP binding to DTBS, we superimposed the structure of EcDTBS in complex with ATP (PDB # 1A82 [14] ) and HpDTBS in complex with ATP or GDP (PDB # 3QXC, 3QXX [18] ) onto the CTP bound MtDTBS structure. In the published X-ray structures, ATP and GTP both adopt an extended conformation that would cause a significant steric clash with MtDTBS in the nucleotide-
binding pocket. Compared to the more open pockets observed in EcDTBS and
HpDTBS, MtDTBS has a more constrained pocket due to additional strands at the Cterminus of the enzyme. Presumed flexibility at the loops formed by G169 -W171 and A195 -A201 would allow accommodation of other NTPs in the nucleotide pocket.
The biological significance of the selective binding reported here may be a function of the concentrations of NTPs found in different bacteria. For E. coli and Salmonella enterica, it has been reported that ATP is the most abundant NTP, with concentrations being at least 3 mM [36] and [37] . This is >300 times above the K M for ATP measured in this study for EcDTBS suggesting that ATP is constantly at saturating concentrations in vivo. The levels of various NTPs can decrease as E. coli transitions from growth to stationary phase. Interestingly, of all the NTPs, CTP had the most constant concentration throughout the whole growth curve, with only minor fluctuations in its levels. In Mycobacteria there is an abundant supply of all NTPs during all stages of cell growth [38] . Here nucleoside diphosphate kinase plays an important role in NTP synthesis by utilizing both purine and pyrimidine NDP as substrates to produce NTPs.
Nucleoside diphosphate kinase can also form complexes with several proteins, and this has been shown to alter the specificity of substrate binding thereby directing the synthesis of specific NTPs as required during active cell growth. For example, M.
tuberculosis cell wall protein A, a homologue of protein P 60 in Mycobacterium smegmatis, can induce the specificity of nucleoside diphosphate kinase towards CTP synthesis [39] . Therefore, we propose that the broad specificity observed in this study for the MtDTBS provides the tuberculi with the potential to scavenge alternative NTPs depending upon availability. This previously unrecognized mechanism ensures that the activity of this important enzyme, and the biotin biosynthetic pathway, is maintained. Fig. 1 . NTP specificity. The specificity of MtDTBS (black bars) and EcDTBS (white bars)
FIGURE LEGENDS
for different nucleotides was measured in the presence of 0.1 mM DAPA, 10 mM NaHCO 3 , and 0.3 mM NTP. The specificity is presented as the percentage of enzyme activity normalized to 100% of enzyme activity using ATP. Residues interacting with the substrate CTP in the DTBS active site are shown in this figure, prepared using Ligplot. The concentration of DTB was determined from a standard curve generated by incubating 25 nM fluorescein-biotin and 20 nM streptavidin with varying amounts of DTB. Each DTB concentration was assayed in triplicate, and the data points represented on the graph represent the mean ± SEM. 
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SUPPLEMENTARY EXPERIMENTAL PROCEDURES
Surface Plasmon Resonance
The kinetics of the interaction between DTBS and NTPs were analysed using a BIAcore T100. DTBS enzymes were immobilized onto the surface of a CM5 sensor chip using amide-coupling chemistry. After activating the surface with EDC and NHS, DTBS solution at concentration of 0.2 mg ml -1 in 0.01 M sodium acetate buffer pH 5.2 was applied at a constant flow rate of 5 µl min -1 for 420 s. Approximately 10,000 response units (RU) of ligands were immobilized. Typically, no immobilized ligand (empty flow cell) and immobilized bovine serum albumin (BSA) were performed alongside immobilized DTBS in order to correct for bulk refractive index changes with buffer and distinguish non-specific binding events, respectively. Water-soluble NTPs were diluted in running buffer (10 mM HEPES (pH 7.4), 150 mM NaCl and 0.005% (v/v) surfactant P20). Binding experiments were performed by injecting the analyte solutions across the sensor surface of all flow cells at a flow rate of 30 µl min -1 with a contact time of 60 sec followed by a dissociation time of 60 sec. The time-dependent binding curves from all four flow cells were monitored simultaneously.
As the analyte bound to the immobilized DTBS, the refractive index at the surface alters in proportion to the change in mass, resulting in change of RU value. The binding capacity of the surface depends on the level and activity of immobilized ligand. The maximum binding capacity (R MAX ) of the immobilized ligand was calculated using Equation 1 where MW is the molecular weight of the ligand and analyte, RL is the amount of immobilized ligand in RU, and S M is the stoichiometry as defined by the number of binding sites on the ligand (Guiducci, 2010) . The percent activity of the immobilized ligand that reflects the quality of binding was determined using Equation 2 (Guiducci, 2010). The binding affinity (K D ) was determined by transforming the time-dependent binding curves into an affinity steady-state 1:1 model using BIAcore T100 evaluation software (GE Healthcare).
Mass Spectrometry
LC-ESI-MS/MS was acquired using an 1100 series HPLC system (Agilent Technologies) coupled via an Advance CaptiveSpray source (Michrom Bioresources, Inc.) to an amaZon ETD mass spectrometer (Bruker Daltonics). Samples were initially run on a 4-12% gradient SDS-PAGE gel and stained with coomassie blue dye. Bands were excised from the gel manually and processed with a trypsin digestion protocol (Shevchenko et al., 2006) . Collision-induced dissociation (CID) spectra were acquired to
